GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $435,000 | +55.4% | 10,004 | +55.9% | 0.00% | – |
| Q1 2022 | $280,000 | +5.7% | 6,418 | +6.9% | 0.00% | – |
| Q4 2021 | $265,000 | -68.5% | 6,004 | -72.8% | 0.00% | – |
| Q3 2021 | $842,000 | +270.9% | 22,047 | +286.7% | 0.00% | – |
| Q2 2021 | $227,000 | -41.8% | 5,701 | -47.9% | 0.00% | – |
| Q1 2021 | $390,000 | -74.4% | 10,936 | -73.6% | 0.00% | – |
| Q4 2020 | $1,526,000 | +19.9% | 41,454 | +22.6% | 0.00% | – |
| Q3 2020 | $1,273,000 | -18.8% | 33,810 | -12.0% | 0.00% | -100.0% |
| Q2 2020 | $1,568,000 | -93.5% | 38,430 | -93.9% | 0.00% | -90.0% |
| Q1 2020 | $23,967,000 | -20.5% | 632,569 | -1.3% | 0.01% | +11.1% |
| Q4 2019 | $30,131,000 | +9.2% | 641,203 | -0.8% | 0.01% | +28.6% |
| Q3 2019 | $27,598,000 | +7.0% | 646,624 | +0.4% | 0.01% | 0.0% |
| Q2 2019 | $25,786,000 | +476.9% | 644,331 | +502.4% | 0.01% | +250.0% |
| Q1 2019 | $4,470,000 | -9.1% | 106,961 | -16.9% | 0.00% | 0.0% |
| Q4 2018 | $4,917,000 | -17.0% | 128,683 | -12.8% | 0.00% | 0.0% |
| Q3 2018 | $5,925,000 | +11.3% | 147,488 | +11.7% | 0.00% | 0.0% |
| Q2 2018 | $5,322,000 | -12.6% | 132,011 | -15.3% | 0.00% | 0.0% |
| Q1 2018 | $6,090,000 | -5.9% | 155,870 | -14.6% | 0.00% | 0.0% |
| Q4 2017 | $6,471,000 | -18.3% | 182,418 | -6.5% | 0.00% | -33.3% |
| Q3 2017 | $7,917,000 | -3.8% | 195,001 | +2.2% | 0.00% | 0.0% |
| Q2 2017 | $8,230,000 | +9.7% | 190,873 | +7.3% | 0.00% | +50.0% |
| Q1 2017 | $7,503,000 | +19.7% | 177,960 | +9.4% | 0.00% | 0.0% |
| Q4 2016 | $6,267,000 | -83.4% | 162,724 | -81.4% | 0.00% | -84.6% |
| Q3 2016 | $37,696,000 | +1.2% | 874,033 | +1.7% | 0.01% | -7.1% |
| Q2 2016 | $37,257,000 | +5.1% | 859,654 | -1.7% | 0.01% | 0.0% |
| Q1 2016 | $35,444,000 | -73.2% | 874,085 | -73.3% | 0.01% | -73.6% |
| Q4 2015 | $132,018,000 | -0.4% | 3,271,827 | -5.0% | 0.05% | -5.4% |
| Q3 2015 | $132,489,000 | -38.3% | 3,445,757 | -33.2% | 0.06% | -33.3% |
| Q2 2015 | $214,743,000 | -37.9% | 5,155,903 | -31.2% | 0.08% | -37.3% |
| Q1 2015 | $345,653,000 | +1.5% | 7,489,758 | -6.0% | 0.13% | +1.5% |
| Q4 2014 | $340,610,000 | -4.1% | 7,969,344 | +3.2% | 0.13% | -7.0% |
| Q3 2014 | $355,140,000 | +56.0% | 7,725,459 | +81.5% | 0.14% | +57.8% |
| Q2 2014 | $227,592,000 | -23.8% | 4,255,632 | -23.8% | 0.09% | -25.6% |
| Q1 2014 | $298,507,000 | -5.3% | 5,586,868 | -5.3% | 0.12% | -3.2% |
| Q4 2013 | $315,107,000 | +6.5% | 5,902,007 | +0.0% | 0.12% | -3.1% |
| Q3 2013 | $295,990,000 | -8.4% | 5,899,729 | -8.8% | 0.13% | -14.6% |
| Q2 2013 | $323,236,000 | – | 6,468,609 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |